76 related articles for article (PubMed ID: 2823391)
1. [Central depressor effect of U50488H: a highly selective kappa opioid agonist].
Feng Y; Han JS
Sheng Li Xue Bao; 1987 Jun; 39(3):305-9. PubMed ID: 2823391
[No Abstract] [Full Text] [Related]
2. Selective kappa opioid agonist for spinal analgesia without the risk of respiratory depression.
Castillo R; Kissin I; Bradley EL
Anesth Analg; 1986 Apr; 65(4):350-4. PubMed ID: 3006552
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel class of highly potent sigma ligands related to the kappa-selective agonist U50,488.
Radesca LA; deCosta BR; Bowen WD; DiPaolo LJ; Rice KC
NIDA Res Monogr; 1990; 105():518-9. PubMed ID: 1652089
[No Abstract] [Full Text] [Related]
4. Activation of kappa opioid receptors by U50488H and morphine enhances the release of substance P from rat trigeminal nucleus slices.
Suarez-Roca H; Maixner W
J Pharmacol Exp Ther; 1993 Feb; 264(2):648-53. PubMed ID: 7679733
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular depressant effects of the kappa opioid receptor agonists U50488H and spiradoline mesylate.
Hall ED; Wolf DL; McCall RB
Circ Shock; 1988 Dec; 26(4):409-17. PubMed ID: 2850873
[TBL] [Abstract][Full Text] [Related]
6. U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist.
Vonvoigtlander PF; Lahti RA; Ludens JH
J Pharmacol Exp Ther; 1983 Jan; 224(1):7-12. PubMed ID: 6129321
[TBL] [Abstract][Full Text] [Related]
7. Kappa opiate agonists modulate the hypothalamic-pituitary-adrenocortical axis in the rat.
Iyengar S; Kim HS; Wood PL
J Pharmacol Exp Ther; 1986 Aug; 238(2):429-36. PubMed ID: 3016237
[TBL] [Abstract][Full Text] [Related]
8. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of nitric oxide synthase enhances antinociception mediated by mu, delta and kappa opioid receptors in acute and prolonged pain in the rat spinal cord.
Machelska H; Labuz D; Przewłocki R; Przewłocka B
J Pharmacol Exp Ther; 1997 Aug; 282(2):977-84. PubMed ID: 9262366
[TBL] [Abstract][Full Text] [Related]
10. Differential activity of selective opioid agonists on hypothalamic magnocellular neuronal activity.
Clarke G; Davison I; MacMillan SJ; Wright DM
Prog Clin Biol Res; 1990; 328():351-4. PubMed ID: 2154792
[No Abstract] [Full Text] [Related]
11. Dynorphin A and related peptides administered intrathecally in the rat: a search for putative kappa opiate receptor activity.
Stevens CW; Yaksh TL
J Pharmacol Exp Ther; 1986 Sep; 238(3):833-8. PubMed ID: 2875172
[TBL] [Abstract][Full Text] [Related]
12. Characterization of putative kappa opioid-sensitive cells of the substantia nigra pars reticulata.
Thompson LA; Walker JM
Prog Clin Biol Res; 1990; 328():335-8. PubMed ID: 2154790
[No Abstract] [Full Text] [Related]
13. The selective kappa-opioid agonist, U-50,488H, produces antinociception in the rat via a supraspinal action.
Czlonkowski A; Millan MJ; Herz A
Eur J Pharmacol; 1987 Oct; 142(1):183-4. PubMed ID: 2826175
[No Abstract] [Full Text] [Related]
14. U50,488, a highly selective kappa opioid: anticonvulsant profile in rats.
Tortella FC; Robles L; Holaday JW
J Pharmacol Exp Ther; 1986 Apr; 237(1):49-53. PubMed ID: 3007743
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of L-type calcium currents in guinea pig ventricular myocytes by the kappa-opioid agonist U50488H does not involve binding to opiate receptors.
Utz J; Eckert R; Trautwein W
J Pharmacol Exp Ther; 1995 Aug; 274(2):627-33. PubMed ID: 7543570
[TBL] [Abstract][Full Text] [Related]
16. Influence of a mu- and kappa-opioid agonist on isoflurane minimal anesthetic concentration in chickens.
Concannon KT; Dodam JR; Hellyer PW
Am J Vet Res; 1995 Jun; 56(6):806-11. PubMed ID: 7653892
[TBL] [Abstract][Full Text] [Related]
17. Similar actions of kappa and mu agonists on spinal nociceptive reflexes in rats and their reversibility by naloxone.
Parsons CG; West DC; Headley PM
NIDA Res Monogr; 1986; 75():461-4. PubMed ID: 2828992
[TBL] [Abstract][Full Text] [Related]
18. Respiratory effects of receptor-selective opioids in rhesus monkeys.
France CP; Woods JH
Prog Clin Biol Res; 1990; 328():295-8. PubMed ID: 2154784
[No Abstract] [Full Text] [Related]
19. A new analysis of whole-body calorimetry data.
Lynch TJ; Martinez RP; Furman MB; Geller EB; Adler MW
NIDA Res Monogr; 1989; 95():289-90. PubMed ID: 2561834
[No Abstract] [Full Text] [Related]
20. Mechanisms involved in the hypotensive effect of a kappa-opioid receptor agonist in hypertensive rats.
Guo HT; Zhang RH; Huang LY; Li J; Liu YL; Bi H; Zhang QY; Wang YM; Sun X; Ma XL; Cheng L; Liu JC; Yu SQ; Yi DH; Pei JM
Arch Med Res; 2007 Oct; 38(7):723-9. PubMed ID: 17845890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
